早期非小细胞肺癌放疗中局部控制与总生存相关:一项系统综述
该系统综述纳入87项研究、13435例接受放疗的周围型早期非小细胞肺癌患者,通过meta回归分析发现3年局部控制率与3年总生存、癌症特异生存、无病生存及无远处转移生存均相关;多因素分析显示3年局部控制和T1比例与3年总生存及癌症特异生存显著相关,≥3级毒性发生率为3.4%。
要点
- 3年局部控制率与3年总生存相关(多因素系数0.561,95%CI 0.254-0.830,p<0.001)。
- 3年局部控制率提高5%,预计3年癌症特异生存和总生存分别提高3.8%和2.8%。
- ≥3级毒性发生率低,为3.4%。
核心结论
- 在接受放疗的早期非小细胞肺癌患者中,3年局部控制率与3年总生存相关。
- 3年局部控制率提高5%,预计可使3年癌症特异生存率和总生存率分别提高3.8%和2.8%。
研究设计与样本
- 系统综述,纳入接受放疗的周围型早期非小细胞肺癌(主要分期为T1-2N0M0)患者的研究。
- 最终从87项研究中提取101个数据点,共包含13435例患者进行定量合成。
主要发现
- 单因素meta回归显示,3年局部控制率与3年无病生存的系数为0.753(95%CI 0.307-1.199,p<0.001)。
- 3年局部控制率与3年无远处转移生存的系数为0.360(95%CI 0.128-0.593,p=0.002)。
- 3年局部控制率与3年癌症特异生存的系数为0.766(95%CI 0.489-1.044,p<0.001)。
- 3年局部控制率与3年总生存的系数为0.574(95%CI 0.275-0.822,p<0.001)。
- 多因素分析显示,3年局部控制率(系数0.561,95%CI 0.254-0.830,p<0.001)和T1比例(系数0.207,95%CI 0.030-0.385,p=0.012)与3年总生存显著相关;3年局部控制率(系数0.720,95%CI 0.468-0.972,p<0.001)和T1比例(系数0.002,95%CI 0.000-0.003,p=0.012)与3年癌症特异生存显著相关。
关键数值与推荐
- ≥3级毒性发生率低,为3.4%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Local control (LC) is an important outcome of local cancer therapy, besides overall survival (OS). We conducted a comprehensive literature search to investigate whether a high LC rate contributes to good OS in radiotherapy for early-stage non-small cell lung cancer (ES-NSCLC). MATERIALS AND METHODS: Studies in patients receiving radiotherapy for peripheral ES-NSCLC, mainly staged as T1-2N0M0 were included for a systematic review. Relevant information was collected including, dose fractionation, T stage, median age, 3-year LC, cancer-specific survival (CSS), disease-free survival (DFS), distant metastasis-free survival (DMFS), and OS. Correlations between outcomes and clinical variables were evaluated. RESULTS: After screening, 101 data points from 87 studies including 13,435 patients were selected for the quantitative synthesis. Univariate meta-regression analysis revealed that the coefficients between the 3-year LC and 3-year DFS, DMFS, CSS, and OS were 0.753 (95% confidence interval (CI): 0.307-1.199; p < 0.001), 0.360 (95% CI: 0.128-0.593; p = 0.002), 0.766 (95% CI: 0.489-1.044; p < 0.001), and 0.574 (95% CI: 0.275-0.822; p < 0.001), respectively. Multivariate analysis revealed that the 3-year LC (coefficient, 0.561; 95% CI: 0.254-0.830; p < 0.001) and T1 proportion (coefficient, 0.207; 95% CI: 0.030-0.385; p = 0.012) were significantly associated with the 3-year OS and CSS (coefficient for 3-year LC, 0.720; 95% CI: 0.468-0.972; p < 0.001 and T1 proportion, 0.002; 95% CI: 0.000-0.003; p = 0.012). Toxicities ≥ grade 3 were low (3.4%). CONCLUSIONS: Three-year LC was correlated with three-year OS in patients receiving radiotherapy for ES-NSCLC. A 5% increase in 3-year LC is expected to improve the 3-year CSS and OS rates by 3.8% and 2.8%, respectively.
引用
- Sanuki N, Takeda A, Eriguchi T, et al. Local control correlates with overall survival in radiotherapy for early-stage non-small cell lung cancer: A systematic review. Radiother Oncol. 2023. PMID: 37024056. doi:10.1016/j.radonc.2023.109664
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。